RESEARCH TRIANGLE PARK, NC — February 18, 2026 — Lightship Inc., the modern clinical trial site organization committed to making research possible for all, today announced that it has selected and implemented CRIO’s integrated eSource and site clinical trial management system (CTMS) to further standardize site workflows and strengthen operational visibility across its expanding network.
“Sponsors need confidence that site execution will be consistent across locations and over time,” said Darcy Forman, Chief Operating Officer of Lightship. “This implementation helps us standardize how work gets done, builds on the visibility we have across our network, and supports high-quality trial delivery as we scale.”
Lightship partners with biopharmaceutical companies and CROs to design and conduct studies that expand access and choice for research participants while supporting strong trial execution. Lightship facilitates flexible visit options, including in-clinic, at home, and on mobile research units, with a focus on reducing burden for participants and study teams.
With CRIO in place, Lightship will centralize key operational functions across its site network, including study operations, reporting, and oversight workflows, for repeatable execution across studies and locations. CRIO’s integrated eSource and site CTMS capabilities are intended to streamline site workflows, reduce administrative friction for teams, and strengthen operational insight across active programs.
CRIO is an eSource solution that enables data capture at the point of participant interaction to help reduce site burden and support protocol compliance. CRIO’s site CTMS integrates with the eSource platform to streamline site operations. For sponsors and CRO partners, this implementation reinforces:
- More consistent workflows across an expanding site network
- Stronger operational visibility through centralized site activity tracking and reporting
- Repeatable execution across in-clinic, hybrid, and flexible visit models
“Site networks need systems that scale with their growth and standardize execution across studies and sites,” said Jonathan Andrus, co-CEO at CRIO. “We’re excited to support Lightship with an integrated eSource and site CTMS platform designed to centralize site operations, strengthen visibility, and reduce administrative burden for study teams.”
To learn more about Lightship’s site network and trial delivery model, including how to partner, visit https://lightship.com.
About Lightship Inc.
Lightship Inc. is a modern clinical trial site organization committed to making research participation possible for all. We collaborate with biopharma and CROs to design and conduct studies that expand access and choice while accelerating new therapies. Through in-clinic, at-home, and mobile research unit visits, we support individuals from first contact to completion and deliver shorter timelines, stronger participant retention, greater diversity, and consistent quality and safety. At Lightship, we redefine what it means to be a clinical trial site. For more information, visit https://lightship.com.
Media Contact for Lightship:
Brittany Kearns
Crossroads B2B Marketing on behalf of Lightship
571-271-7211
About CRIO
CRIO is a leading provider of eSource solutions for clinical research. The platform streamlines data collection and management, ensuring protocol compliance and reducing errors. By eliminating paper source and automating workflows, CRIO helps clinical trial sites and sponsors save time and money, improve data quality, and enhance patient safety. Our digital-first, site-centric approach makes clinical trials more efficient and effective. Learn more at clinicalresearch.io.
Media Contact for CRIO
Julie Colman
Largemouth Communications on behalf of CRIO
919-459-6450
